Home dialysis and Covid-19 in french speaking countries (RDPLF data-base)

C. Verger, E. Fabre, P. Durand, J. Chanliau, I. Vernier, M. Dratwa
{"title":"Home dialysis and Covid-19 in french speaking countries (RDPLF data-base)","authors":"C. Verger, E. Fabre, P. Durand, J. Chanliau, I. Vernier, M. Dratwa","doi":"10.25796/bdd.v4i3.63003","DOIUrl":null,"url":null,"abstract":"Aims of the study: to assess the frequency of symptomatic Covid-19 in home dialysis patients and its influence on the number of patients treated at home in dialysis units of centers included in the French-speaking peritoneal and home hemodialysis Registry (RDPLF). Focus is placed on patients treated by peritoneal dialysis (PD) in mainland France. \nResults: in home hemodialysis (HHD)the incidence is 6% in Belgium and 4.8% in mainland France. On peritoneal dialysis it is 10.6% in Belgium, 6.7% in mainland France, 10.8% in Morocco and 11.5% in Tunisia. Lethality is less than 5% in HHD and between 8.4% and 42.7% in PD depending on age and associated comorbidities. In France, the percentage of patients who have had symptomatic Covid-19 is lower on home dialysis, all methods combined. Nevertheless, among the home methods, the higher frequencies and severities are observed in mainland France in home assisted PD: these are the oldest and most co-morbid patients. Transfers from PD to in center hemodialysis have increased during Covid-19 pandemic while the number of transplants has decreased. \nConclusion: if the drop in the number of transplants can be explained by a reduced availability of operating theaters and surgical teams during a pandemic period, it is paradoxical that the prescription of home dialysis, which should be supposed to limit the risk of contagion, has decreased. More investigation should be performed to understand this paradox. \n ","PeriodicalId":366938,"journal":{"name":"Bulletin de la Dialyse à Domicile","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin de la Dialyse à Domicile","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25796/bdd.v4i3.63003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims of the study: to assess the frequency of symptomatic Covid-19 in home dialysis patients and its influence on the number of patients treated at home in dialysis units of centers included in the French-speaking peritoneal and home hemodialysis Registry (RDPLF). Focus is placed on patients treated by peritoneal dialysis (PD) in mainland France. Results: in home hemodialysis (HHD)the incidence is 6% in Belgium and 4.8% in mainland France. On peritoneal dialysis it is 10.6% in Belgium, 6.7% in mainland France, 10.8% in Morocco and 11.5% in Tunisia. Lethality is less than 5% in HHD and between 8.4% and 42.7% in PD depending on age and associated comorbidities. In France, the percentage of patients who have had symptomatic Covid-19 is lower on home dialysis, all methods combined. Nevertheless, among the home methods, the higher frequencies and severities are observed in mainland France in home assisted PD: these are the oldest and most co-morbid patients. Transfers from PD to in center hemodialysis have increased during Covid-19 pandemic while the number of transplants has decreased. Conclusion: if the drop in the number of transplants can be explained by a reduced availability of operating theaters and surgical teams during a pandemic period, it is paradoxical that the prescription of home dialysis, which should be supposed to limit the risk of contagion, has decreased. More investigation should be performed to understand this paradox.  
法语国家的家庭透析与Covid-19 (RDPLF数据库)
本研究的目的:评估家庭透析患者中出现症状性Covid-19的频率及其对法语腹膜和家庭血液透析登记处(RDPLF)所包括的中心透析单元中在家接受治疗的患者人数的影响。重点是在法国大陆接受腹膜透析(PD)治疗的患者。结果:在家庭血液透析(HHD)中,比利时的发生率为6%,法国大陆为4.8%。在腹膜透析方面,比利时为10.6%,法国大陆为6.7%,摩洛哥为10.8%,突尼斯为11.5%。HHD的死亡率低于5%,PD的死亡率在8.4%到42.7%之间,这取决于年龄和相关的合共病。在法国,所有方法加起来,有症状的Covid-19患者在家庭透析中的比例较低。然而,在家庭方法中,在法国大陆观察到家庭辅助PD的频率和严重程度较高:这些患者年龄最大,合并症最多。在Covid-19大流行期间,从PD到中心血液透析的转移增加了,而移植数量却减少了。结论:如果移植数量的下降可以用大流行期间手术室和手术团队的减少来解释,那么应该限制传染风险的家庭透析处方却减少了,这是自相矛盾的。应该进行更多的调查来理解这一矛盾。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信